AvenovaTM as a Sterile Skin Preparation Agent

• Status: Completed
• Trial end date: 2019-12-20
• Target enrollment: 0
• Participant gender: All

Summary

Aim 1: To determine in vivo capability of AvenovaTM against common cutaneous microbial biome on human skin

Aim 2: To compare to povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol against AvenovaTM as a sterile skin agent

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Miami
• Treatments: Chlorhexidine; Chlorhexidine gluconate; Ethanol; Iodine; Pharmaceutical Solutions; Povidone; Povidone-Iodine

Criteria

Inclusion Criteria:

• Adults age 18 and above able to provide informed consent to participate Adults attending Dr. Wendy Lee Oculoplastics Clinic

Exclusion Criteria:

• Adults unable to consent

• Individuals who less than 18 years of age

• Prisoners

• Pregnant women - while these cleansing agents are used on pregnant women as standard cleansing agents, effects to fetus unknown

• Patients currently using oral or topical antimicrobial agents

• History of skin infection to facial injectable of surgery

• Inability to tolerate cleansing procedure

• Inability to sit comfortably for 15 - 30 minutes